REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
44,747,389
Share change
+6,248,901
Total reported value
$3,843,255,917
Put/Call ratio
62%
Price per share
$85.95
Number of holders
264
Value change
+$537,670,761
Number of buys
143
Number of sells
99

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2019

As of 30 Jun 2019, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 264 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,747,389 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., WELLINGTON MANAGEMENT GROUP LLP, FRED ALGER MANAGEMENT INC, STATE STREET CORP, Conestoga Capital Advisors, LLC, FEDERATED INVESTORS INC /PA/, MACQUARIE GROUP LTD, and DIMENSIONAL FUND ADVISORS LP. This page lists 264 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.